Trademark: 87871412
Word
MYRELLIA
Status
Dead
Status Code
606
Status Date
Monday, October 25, 2021
Serial Number
87871412
Mark Type
4000
Filing Date
Tuesday, April 10, 2018
Published for Opposition
Tuesday, July 24, 2018
Abandoned Date
Monday, October 25, 2021

Trademark Owner History
Allergan Sales, LLC - Owner At Publication

Classifications
5 Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of central nervous system disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body

Trademark Events
Oct 25, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 25, 2021
Abandonment - No Use Statement Filed
Mar 20, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 19, 2021
Extension 5 Granted
Mar 8, 2021
Extension 5 Filed
Mar 19, 2021
Case Assigned To Intent To Use Paralegal
Mar 8, 2021
Teas Extension Received
Sep 11, 2020
Notice Of Approval Of Extension Request E-Mailed
Sep 9, 2020
Extension 4 Granted
Sep 9, 2020
Extension 4 Filed
Sep 9, 2020
Teas Extension Received
Mar 11, 2020
Notice Of Approval Of Extension Request E-Mailed
Mar 9, 2020
Extension 3 Granted
Mar 9, 2020
Extension 3 Filed
Mar 9, 2020
Teas Extension Received
Sep 17, 2019
Notice Of Approval Of Extension Request E-Mailed
Sep 13, 2019
Extension 2 Granted
Sep 13, 2019
Extension 2 Filed
Sep 13, 2019
Teas Extension Received
Mar 5, 2019
Notice Of Approval Of Extension Request E-Mailed
Mar 1, 2019
Extension 1 Granted
Mar 1, 2019
Extension 1 Filed
Mar 1, 2019
Teas Extension Received
Sep 18, 2018
Noa E-Mailed - Sou Required From Applicant
Jul 24, 2018
Official Gazette Publication Confirmation E-Mailed
Jul 24, 2018
Published For Opposition
Jul 4, 2018
Notification Of Notice Of Publication E-Mailed
Jun 14, 2018
Approved For Pub - Principal Register
Jun 14, 2018
Assigned To Examiner
Apr 19, 2018
New Application Office Supplied Data Entered In Tram
Apr 13, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24